The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

ActiveDriver: Finding Cancer Driver Proteins with Enriched Mutations in Post-Translational Modification Sites

A mutation analysis tool that discovers cancer driver genes with frequent mutations in protein signalling sites such as post-translational modifications (phosphorylation, ubiquitination, etc). The Poisson generalised linear regression model identifies genes where cancer mutations in signalling sites are more frequent than expected from the sequence of the entire gene. Integration of mutations with signalling information helps find new driver genes and propose candidate mechanisms to known drivers. Reference: Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers. Juri Reimand and Gary D Bader. Molecular Systems Biology (2013) 9:637 <doi:10.1038/msb.2012.68>.

Version: 1.0.0
Depends: R (≥ 3.0)
Imports: stats, parallel, MASS
Published: 2017-08-23
DOI: 10.32614/CRAN.package.ActiveDriver
Author: Juri Reimand [aut, cre]
Maintainer: Juri Reimand <juri.reimand at utoronto.ca>
License: GPL-2 | GPL-3 [expanded from: GPL (≥ 2)]
NeedsCompilation: no
CRAN checks: ActiveDriver results

Documentation:

Reference manual: ActiveDriver.pdf

Downloads:

Package source: ActiveDriver_1.0.0.tar.gz
Windows binaries: r-devel: ActiveDriver_1.0.0.zip, r-release: ActiveDriver_1.0.0.zip, r-oldrel: ActiveDriver_1.0.0.zip
macOS binaries: r-release (arm64): ActiveDriver_1.0.0.tgz, r-oldrel (arm64): ActiveDriver_1.0.0.tgz, r-release (x86_64): ActiveDriver_1.0.0.tgz, r-oldrel (x86_64): ActiveDriver_1.0.0.tgz

Linking:

Please use the canonical form https://CRAN.R-project.org/package=ActiveDriver to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.